VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
This study aims to assess the safety and efficacy of study drugs and supplements on clinical
(structural and functional) signs of aging and to explore/identify other possible biological
measures of aging.